Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

Regenxbio Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
RGNX
Regional Health Properties, Inc
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. Its business primarily consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. Its portfolio of more than 20 properties is diversified across various states, with concentrations in Georgia and Ohio.
RHEP
Regional Management Corp.
Regional Management Corp offers an array of secured loan products to customers with limited access to other sources of credit. The company's only reportable segment is the consumer finance. It offers small loans and large installment loans ranging from $500 to $20,000; automobile loans; retail loans secured by the item purchased; and credit insurance products. Small loans, which are for less than $2,500 and fewer than 36 months, account for roughly half of Regional's total loans outstanding and have the highest yields of all its products. The company's principal source of revenue is interest and fee income on outstanding loans.
RM
Regions Financial Corp
Regions Financial is a regional bank headquartered in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, insurance, and trust services.
RF
Regis Corp
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, telecom, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority of revenue from the United States.
RGS
Rego Payment Architectures, Inc.
Rego Payment Architectures Inc is a technology company focused on delivering an online e-commerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings, and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use. Geographically all the business activity functions through the region of the United States and it derives revenue in the form of subscription, service fees, transaction fees, and revenue sharing with banking and distribution partners.
RPMT
Regulus Therapeutics Inc.
No description
RGLS
Rein Therapeutics, Inc.
Rein Therapeutics, Inc., formerly Aileron Therapeutics, Inc., is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class therapies to address significant unmet medical needs in orphan pulmonary and fibrosis indications. The Company's lead product candidate, LTI-03 (idiopathic pulmonary fibrosis), is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Its second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions. LTI-01 has received Orphan Drug Designation in the United States and European Union and Fast Track Designation in the United States. Its pipeline also includes LTI-05 (cystic fibrosis).
RNTX
Reinsurance Group Of America Inc
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
RGA
Reitar Logtech Holdings Ltd
Reitar Logtech provides comprehensive logistics solutions by connecting capital partners, logistics operators, and its innovative integration and application of logistics technologies through its end-to-end logistics solution business model. Our business primarily consists of two segments: (i) asset management and professional consultancy services, and (ii) construction management and engineering design services. As one of the first movers into the property logistics technology, or PLT, solution industry in Hong Kong, we have been operating in the logistics solution market since 2015 and two of our co-founders and directors have been working in this sector for over 20 years. We provide PLT solutions through Reitar Group, and construction management and engineering design services through Kamui Group.
RITR
Rekor Systems, Inc.
Rekor Systems Inc is a United States-based company. It is engaged in providing real-time roadway intelligence through AI-driven decisions. Rekor bridges commercial and government sectors with actionable, real-time vehicle recognition data. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. Its machine learning software can turn most IP cameras into accurate vehicle recognition devices used to help protect lives, increase brand loyalty, and enhance operations and logistics. Its geographical segments are the United States, Canada, and Others, of which the majority of its revenue comes from the United States.
REKR
Relay Therapeutics, Inc.
Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020.
RLAY
Relevant Gold Corp.
Relevant Gold Corp is a mineral resource company. The company is focused on the acquisition, exploration, discovery, and development of district-scale gold projects in the state of Wyoming.
RGCCF
Reliability Inc
Reliability Inc is a provider of employer of record (EOR) and temporary media and information technology (IT) staffing services. It operates within three industry segments: EOR, Recruiting and Staffing, Video and Multimedia Production, and others. The EOR segment which generates a majority of revenue for the company provides media field talent to a host of large corporate customers.
RLBY
Reliance Global Group, Inc.
Reliance Global Group, Inc. operates as a holding company with diversified interests in the insurance and real estate markets. The Company is focused on acquiring growing, cash flow positive insurance agencies. Within the real estate segment, the Company is involved in acquiring, owning, leasing, managing, and redeveloping multifamily residential properties throughout the U.S. for risk-adjusted returns.
RELI
Reliance, Inc.
Reliance, Inc. is a diversified metal solutions provider and has a metals service center company in North America. The Company provides value-added metals processing services and distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, specialty carbon and alloy steel plate and round bar and specialty steel products. It serves various industries, such as general manufacturing, non-residential construction (including infrastructure), transportation (rail, truck trailer and shipbuilding), aerospace (commercial, military, defense, and space, and heavy industry, energy (oil and natural gas). It also services the auto industry, primarily through its toll processing operation. It has a network of approximately 315 locations in 40 states and in 12 foreign countries, including Belgium, Canada, China, France, India, Malaysia, Mexico, Singapore, South Korea, Turkey, the United Arab Emirates and the United Kingdom.
RS
Relief Therapeutics Holding Sa
Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.
RLFTF
Relmada Therapeutics, Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
RLMD
Relx Plc
RELX, formerly known as Reed Elsevier, is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (37% of 2021 sales); risk (34%); legal (22%); and exhibitions (7%). RELX Group has three listings: its primary one in London and two more in New York and Amsterdam.
RELX
Remark Holdings, Inc.
Remark Holdings Inc delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a range of applications within the retail, financial, public safety, and workplace arenas. The company also owns and operates digital media properties that deliver relevant content and e-commerce solutions. The group operates in one segment namely Technology & Data Intelligence segment which provides products and services to customers based upon the data collected and processed by its proprietary data intelligence software.
MARK
Remitly Global, Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
RELY
Remsleep Holdings Inc.
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group is functioned through the region of the United States.
RMSL
Renaissancere Holdings Ltd
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property catastrophe and specialty reinsurance risks. Revenue is primarily derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are property and casualty & specialty.
RNR
Renalytix Plc
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
RNLXY
Renasant Corp
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation primarily operates in the southern United States.
RNST
Renatus Tactical Acquisition Corp I
No description
RTAC
Renew Energy Global Plc
ReNew is the leading decarbonisation solutions company listed on Nasdaq (Nasdaq: RNW, RNWWW). ReNew's clean energy portfolio of 16.3 GW as of November, 2024 is one of the largest globally. In addition to being a major independent power producer in India, we provide end-to-end solutions in a just and inclusive manner in the areas of clean energy, green hydrogen, value-added energy offerings through digitalisation, storage, and carbon markets that increasingly are integral to addressing climate change.
RNW
Renn Fund, Inc.
The investment objective of the Fund is to provide its stockholders with long-term capital appreciation by investing primarily in privately placed convertible debt and equity securities of emerging growth public companies. The Fund seeks to provide returns to stockholders through cash dividends of net investment income and through distributions of realized gains. The fund invests primarily in privately placed convertible debt and equity securities of emerging growth public companies. The Fund seeks to provide returns to stockholders through cash dividends of net investment income and through distributions of realized gains.
RCG
Renovaro Inc.
Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023.
RENB
Renovorx, Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
RNXT